"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Descriptor ID |
D006526
|
MeSH Number(s) |
C02.440.440 C02.782.350.350 C06.552.380.705.440
|
Concept/Terms |
Hepatitis C- Hepatitis C
- Parenterally-Transmitted Non-A, Non-B Hepatitis
- Parenterally Transmitted Non A, Non B Hepatitis
- PT-NANBH
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".
This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 9 | 0 | 9 |
1996 | 12 | 3 | 15 |
1997 | 10 | 2 | 12 |
1998 | 6 | 1 | 7 |
1999 | 6 | 2 | 8 |
2000 | 7 | 5 | 12 |
2001 | 10 | 5 | 15 |
2002 | 23 | 13 | 36 |
2003 | 26 | 16 | 42 |
2004 | 37 | 11 | 48 |
2005 | 57 | 5 | 62 |
2006 | 34 | 8 | 42 |
2007 | 46 | 13 | 59 |
2008 | 35 | 16 | 51 |
2009 | 32 | 7 | 39 |
2010 | 39 | 16 | 55 |
2011 | 44 | 11 | 55 |
2012 | 51 | 2 | 53 |
2013 | 42 | 15 | 57 |
2014 | 46 | 17 | 63 |
2015 | 63 | 10 | 73 |
2016 | 48 | 16 | 64 |
2017 | 56 | 14 | 70 |
2018 | 56 | 8 | 64 |
2019 | 59 | 16 | 75 |
2020 | 66 | 9 | 75 |
2021 | 60 | 3 | 63 |
2022 | 64 | 0 | 64 |
2023 | 53 | 0 | 53 |
2024 | 31 | 8 | 39 |
2025 | 2 | 0 | 2 |
Below are the most recent publications written about "Hepatitis C" by people in Profiles.
-
Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil. J Med Virol. 2025 Feb; 97(2):e70186.
-
A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You're Empowered for Treatment Initiation (YETI) partner trial. Trials. 2025 Jan 22; 26(1):26.
-
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infections. Sci Rep. 2024 11 22; 14(1):29013.
-
Transfusion-transmissible coinfections among US blood donors. Transfusion. 2024 Dec; 64(12):2241-2246.
-
HIV and hepatitis C Virus in internally displaced people with and without injection drug use experience in the region of Shida Kartli, Georgia. BMC Res Notes. 2024 Oct 20; 17(1):315.
-
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma. Ann Surg Oncol. 2025 Jan; 32(1):426-437.
-
Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study. Clin Infect Dis. 2024 Oct 15; 79(4):1109-1116.
-
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study. Viruses. 2024 Sep 30; 16(10).
-
HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020. PLoS One. 2024; 19(9):e0307990.
-
Exploring the Perspectives of Unhoused Adults and Providers Across the HCV Care Continuum. Clin Nurs Res. 2024 Sep; 33(7):519-529.